Tell you what... I have been holding winners while posting here for distraction... It worked great for a few weeks... but the market is crushing my morning plays back to my break even stop on my second piece. In other words its hard to find follow through on the upside or downside during summer maintenance trading. I am going to cease posting here and go workout or surf... during lunch. I will be back in the fall with a new name. I hope you all stay healthy.
I always find this amusing, anybody competent (as he believes he is) trading full time just the last five years would have more made than they could spend many lifetimes. Gnus has been posting for 22+ years and he is still a povit.
Why a new nickname? What's wrong with the old one? Sheesh, where's the follow-thru with kids these days.
1. the new nic is because every time I destroy the vaccine nazi with data and facts... someone above starts trying to out my identity. For instance that person... could be trying to get my wife fired by bring out the shit above... Fortunately... he was wrong again... a. she is vaccinated b. she was not there and would easily be able to prove it. c. he does not know where she works right now.
Dude, even if you start fresh with a brand new identity here, people will figure out who you are and what your old nick is. People have a knack with learning people's typing styles. They will be able to sniff you out eventually. Me? I know for a fact you are not smallfil, as some seem to claim. You and he have totally different writing styles. And I have seen only a smattering of writing from him, because he's had me on ignore for like 5 years or whatever. *shrugs* Welp, happy nick surfing, heh.
https://www.biorxiv.org/content/10.1101/2021.07.28.454085v1.full SARS-CoV-2 Lambda, a new variant of interest, is now spreading in some South American countries; In this study, we demonstrated that three mutations, the RSYLTPGD246-253N, L452Q and F490S mutations, respectively confer resistance to the vaccine-induced antiviral immunity In addition to increasing viral infectivity, the Delta variant exhibits higher resistance to the vaccine-induced neutralization (Mlcochova et al., 2021; Wall et al., 2021b). Similarly, here we showed that the Lambda variant equips not only increased infectivity but also resistance against antiviral immunity.
Let's imagine if we will... a new variant that was complete vaccine evasive in terms of stopping infections from spreading -- but the vaccines still stopped the infected from getting severely ill or hospitalized. In the face of this new variant over 99% of the people in hospitals were still unvaccinated. Furthermore let's surmise that 60% of people infected with this new variant acquired natural anti-body immunity which lasted at least 6 months (aligned with previous research). And that this natural anti-body immunity stopped people from getting infected or spreading the virus variant for the effective 6 month minimum time period. What would be the best public health strategy in face of this new variant? Well the best strategy would be to require nearly everyone vaccinated (somewhere above 95%), fully lockdown the unvaccinated people -- then remove all restrictions on the vaccinated because few of them would get severely ill or hospitalized when infected -- let the new COVID variant rip through vaccinated population so at least 60% of the population will be further naturally protected (for months) against the new variant while not further spreading it to others and not getting severely ill over 99% of the time. Due to the high vaccinated rate very few people would be hospitalized -- so your ERs/ICUs would not be under stress. Even if the virus spills over to the locked-down unvaccinated they only represent under 5% of the population so they would not overly burden medical facilities. The at-risk unvaccinated would be locked down until they got vaccinated -- or the pandemic reached a point where cases were very rare.
False. It is proven science that nonnutrualizing vaccines are the prefect recipe to create more virulent viruses.